Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
The DTP rules documented on this wiki page address 3 separate goals:
|
General Rules for DTP
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Definition of "A dose of pertussis" A dose of pertussis is defined as one of the following:
Rules for Recommending at the CVX Code vs. Vaccine Group Level Within the Primary SeriesGenerally, ICE recommends at the group level rather than a specific CVX code; however, DTP vaccine group recommendations are at the CVX level. When recommending DTP as part of the 3-dose or 5-dose series, the rules below state which CVX code to recommend. For patients >=7 years of age, the rules below also include an override to the series routine recommended age.
Rules for Adolescent Tdap and Recurring Td (Once Primary Series is Complete)Rules for Adolescent Tdap (CVX 115)If the patient has completed the primary DTP series (3-dose or 5-dose), then see the "Recommendation Rules for Adolescent Tdap" below: Recommendation Rules for Adolescent Tdap
Evaluation Rules for Adolescent Tdap
Rules forRecurring Td (CVX 09)Recurring Booster DoseOnce the patient has completed the primary DTP series (3-dose or 5-dose) and has met the requirements for the Adolescent Tdap, a Td (09) a booster dose is needed every 10 years. Recommendation Rules for Recurring Td Booster Dose
Evaluation Rules for Recurring TdRecurring Booster Dose
|
DTP Vaccines
CVX Code | Name | Absolute Minimum Age |
---|---|---|
01 | DTP | |
09 | Td (adult), adsorbed | 7 yrs - 4 days1 |
20 | DTaP | |
28 | DT (pediatric) | |
106 | DTaP, 5 pertussis antigens | |
107 | DTaP, unspecified formulation | |
113 | Td (adult) preservative free | 7 yrs - 4 days1 |
115 | Tdap | 7 yrs - 4 days1 |
138 | Td (adult, not adsorbed) | 7 yrs - 4 days1 |
139 | Td (adult) NOS | 7 yrs - 4 days1 |
Panel | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||
CVX Code Specific Rules
Anchor |
| ||||||||||||||
Anchor | CVXCodeMinimumIntervalBetweenTdap/DTaPandTd/DT | CVXCodeMinimumIntervalBetweenTdap/DTaPandTd/DT | CVX Code Minimum Interval Between Tdap/DTaP and Td/DT
Anchor | ||||
---|---|---|---|---|
|
If Tdap (CVX 115), DTaP (CVX 20, 106, or 107), or DTP (CVX 01) is given below the minimum interval from a Td (CVX 09, 113, 138, 139) or DT (CVX 28), but the shot meets the minimum age, then the Tdap/DTaP/DTP is evaluated as Invalid and the reason code is D_AND_T_INVALID/P_VALID (i.e., Diphtheria and tetanus components invalid due to minimum interval violation, pertussis component valid).
Rule for DT (CVX 28)3
If a patient is administered DT (CVX 28) at:
- <=7 years, evaluate the shot as Valid and return evaluation reason code SUPPLEMENTAL_TEXT and Descriptive Text: "DT should only be administered to children 6 weeks through 6 years of age with a contraindication to pertussis vaccine." (Implementation Note: this text is output via the output_supplemental_text option in ICE. If this feature is not enabled, the text is not output. See the ICE Implementation Guide for details.)
- > 7 years, evaluate the shot as Valid and return evaluation reason code SUPPLEMENTAL_TEXT and Descriptive Text: "Pertussis is needed to complete the series."
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
...
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | DTP 5-dose | 38 days | 42 days (6 weeks) | 2 months | 3 months + 4 weeks | 01, 20, 283, 106, 107, 115*1, 09*2, 113*2, 138*2, 139*2, 22, 50, 102, 110, 120, 130, 132, 146 |
|
2 | DTP 5-dose | 66 days | 70 days (10 weeks) | 4 months | 5 months + 4 weeks | 01, 20, 283, 106, 107, 115*1, 09*2, 113*2, 138*2, 139*2, 22, 50, 102, 110, 120, 130, 132, 146 | |
3 | DTP 5-dose | 94 days | 98 days (14 weeks) | 6 months | 7 months + 4 weeks | 01, 20, 283, 106, 107, 115*1, 09*2, 113*2, 138*2, 139*2, 22, 50, 102, 110, 120, 130, 132, 146 | |
4 | DTP 5-dose | 1 year - 4 days | 15 months | 15 months | 19 months + 4 weeks | 01, 20, 283, 106, 107, 1151, 092, 1132, 1382, 1392, 22, 50, 102, 110, 120, 130, 132, 146 | |
5 | DTP 5-dose | 4 years - 4 days | 4 years | 4 years | 7 years | 01, 20, 283, 106, 107, 1151, 092, 1132, 1382, 1392, 22, 50, 102, 110, 120, 130, 132, 146 |
...
, 110, 120, 130, 132, 146 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
...
Panel | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
Series Special Rules/TD Anchor |
|
Anchor | ||||
---|---|---|---|---|
|
The 5-dose series above applies unless:
Exception 1: Series Complete with 3 Doses
- If the patient is >=7 or will be >=7 as of the next due date, received the first dose at >= 12 months of age, and received at least one dose at >= 4 years1 4 of age, then the series is complete with 3 doses (doses 2, 3 and 4).
Exception 2: Series Complete with 4 Doses
- If 4 doses have been administered and the 4th dose is administered at >= 4 years1 4 of age, then and the interval between dose 3 and 4 is >= 6 months - 4 days, then the series is complete with 4 doses; the 5th (booster) dose is not needed.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
...